Fin Trust Capital Advisors, LLC Glaukos Corp Transaction History

Fin Trust Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $1,381 - $2,247	-48 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $382 - $1,052	15 Added 45.45%	48 $1,000
Q3 2019 Oct 29, 2019	BUY	$58.58 - $83.91 $937 - $1,342	16 Added 94.12%	33 $2,000
Q1 2019 May 09, 2019	BUY	$50.75 - $80.54 $862 - $1,369	17 New	17 $1,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.